Jeffrey S. Parkin

Array ( [id] => 7465400 [patent_doc_number] => 20040101823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'HIV-1 viral variants for improved animal models of HIV-1 pathogenesis' [patent_app_type] => new [patent_app_number] => 10/325468 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 58267 [patent_no_of_claims] => 164 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101823.pdf [firstpage_image] =>[orig_patent_app_number] => 10325468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740324 [patent_doc_number] => 20030157693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Cell lines with latent immunodeficiency virus and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/323463 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17661 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157693.pdf [firstpage_image] =>[orig_patent_app_number] => 10323463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872997 [patent_doc_number] => 20060165715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Gp41 inhibitor' [patent_app_type] => utility [patent_app_number] => 10/499094 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24602 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165715.pdf [firstpage_image] =>[orig_patent_app_number] => 10499094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657143 [patent_doc_number] => 20080026004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'MEMBRANE VIRUS HOST RANGE MUTATIONS AND THEIR USES AS VACCINE SUBSTRATES' [patent_app_type] => utility [patent_app_number] => 10/318727 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8846 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026004.pdf [firstpage_image] =>[orig_patent_app_number] => 10318727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805344 [patent_doc_number] => 20030232738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Method and composition for increasing CD4+ T lymphocyte immune responsiveness' [patent_app_type] => new [patent_app_number] => 10/313923 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20860 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232738.pdf [firstpage_image] =>[orig_patent_app_number] => 10313923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761346 [patent_doc_number] => 20030124708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Modification of virus tropism and host range by viral genome shuffling' [patent_app_type] => new [patent_app_number] => 10/310741 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 37371 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124708.pdf [firstpage_image] =>[orig_patent_app_number] => 10310741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628707 [patent_doc_number] => 20030211117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Synthetic antigen for the detection of aids-related disease' [patent_app_type] => new [patent_app_number] => 10/305271 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8481 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211117.pdf [firstpage_image] =>[orig_patent_app_number] => 10305271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395865 [patent_doc_number] => 20040022799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins' [patent_app_type] => new [patent_app_number] => 10/304494 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19971 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022799.pdf [firstpage_image] =>[orig_patent_app_number] => 10304494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765535 [patent_doc_number] => 20030099934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Chemically modified hiv envelope glycoprotein' [patent_app_type] => new [patent_app_number] => 10/169442 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5701 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099934.pdf [firstpage_image] =>[orig_patent_app_number] => 10169442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696829 [patent_doc_number] => 20030109023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'HIV-producing cell line and uses thereof' [patent_app_type] => new [patent_app_number] => 10/275417 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5637 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109023.pdf [firstpage_image] =>[orig_patent_app_number] => 10275417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846350 [patent_doc_number] => 20030165517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Therapeutic anti-HIV (vpr) compounds' [patent_app_type] => new [patent_app_number] => 10/283618 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165517.pdf [firstpage_image] =>[orig_patent_app_number] => 10283618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026439 [patent_doc_number] => 20050020495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/492189 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1766 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020495.pdf [firstpage_image] =>[orig_patent_app_number] => 10492189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796819 [patent_doc_number] => 20030175693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'HIV recombinant vaccine' [patent_app_type] => new [patent_app_number] => 10/268927 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11712 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175693.pdf [firstpage_image] =>[orig_patent_app_number] => 10268927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641491 [patent_doc_number] => 07122190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 10/267748 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 231994 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122190.pdf [firstpage_image] =>[orig_patent_app_number] => 10267748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314975 [patent_doc_number] => 20040034209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Vaccination of hiv infected persons following highly active antiretrovial therapy' [patent_app_type] => new [patent_app_number] => 10/182067 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14768 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034209.pdf [firstpage_image] =>[orig_patent_app_number] => 10182067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421631 [patent_doc_number] => 07273614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 10/267682 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 206888 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273614.pdf [firstpage_image] =>[orig_patent_app_number] => 10267682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724982 [patent_doc_number] => 20030207294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method for analysing immunodeficiency virus (HIV) phenotypic characteristics' [patent_app_type] => new [patent_app_number] => 10/263655 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10976 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207294.pdf [firstpage_image] =>[orig_patent_app_number] => 10263655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847665 [patent_doc_number] => 20030166832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => new [patent_app_number] => 10/262435 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23958 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166832.pdf [firstpage_image] =>[orig_patent_app_number] => 10262435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433208 [patent_doc_number] => 20040002157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Novel retroviral constructs' [patent_app_type] => new [patent_app_number] => 10/255825 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 14823 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002157.pdf [firstpage_image] =>[orig_patent_app_number] => 10255825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796430 [patent_doc_number] => 20030175304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Recombinant dimeric envelope vaccine against flaviviral infection' [patent_app_type] => new [patent_app_number] => 10/247960 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15376 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175304.pdf [firstpage_image] =>[orig_patent_app_number] => 10247960 [rel_patent_id] =>[rel_patent_doc_number] =>)